Podcast appearances and mentions of sharon cohen

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, Sharon Cohen, MD, a behavioral neurologist, sat down to discuss positive data from an ongoing phase 1 study of mivelsiran (Alnylam Pharmaceuticals), the first investigational RNA interference therapeutic targeting amyloid precursor protein for Alzheimer disease (AD). Cohen, who also serves as the medical director of the Toronto Memory Program at the University of Toronto, discussed the potential of RNA therapeutics for treating AD, the unique mechanism of action of mivelsiran, and some of the early promising safety, efficacy, and pharmacokinetic data observed in the phase 1 trial. In addition, Cohen touched upon the idea of how RNA therapeutics could be used in combination with previously approved novel treatments and the benefits mivelsiran brings with no observed amyloid-related imaging abnormalities. Furthermore, the discussion covered some of the potential of this investigational agent, what to expect in the multi-dose part B of the study, and an additional phase 2 study in cerebral amyloid angiopathy.  Looking for more Alzheimer disease/dementia discussion? Check out the NeurologyLive® Alzheimer disease/dementia clinical focus page. Episode Breakdown: 1:15 – Mechanism of action of mivelsiran and how it can be potentially beneficial in AD 4:15 – Growing knowledge of RNA therapeutics and their impact on neurologic conditions 7:00 – Neurology News Minute 10:10 – Phase 1 study data, including efficacy, safety, biomarker, and pharmacokinetic results 19:20 – How mivelsiran fits with other approved therapies for AD; future goals and directions of the drug The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Clears Indapta Therapeutics' IND for Cell Therapy IDP-023 in Progressive Multiple Sclerosis Muscle-Targeting Therapy Apitegromab Effective in Spinal Muscular Atrophy Over 4 Year Period FDA Approves Medtronic's Deep Brain Stimulation Technology for Asleep Capabilities Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SRN865. CME/MOC/AAPA credit will be available until August 14, 2025.Preparing Specialists for the New Era in Alzheimer's Disease: A Case-Based Exploration of Strategies for Integrating Diagnostic Biomarkers and Amyloid-Targeting Therapies Into Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VQG865. CME/MOC/AAPA credit will be available until May 20, 2025.Specialty Training for the New Era in Alzheimer's Disease: Building Skills for Making an Early Diagnosis and Implementing Disease-Modifying Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VQG865. CME/MOC/AAPA credit will be available until May 20, 2025.Specialty Training for the New Era in Alzheimer's Disease: Building Skills for Making an Early Diagnosis and Implementing Disease-Modifying Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VQG865. CME/MOC/AAPA credit will be available until May 20, 2025.Specialty Training for the New Era in Alzheimer's Disease: Building Skills for Making an Early Diagnosis and Implementing Disease-Modifying Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VQG865. CME/MOC/AAPA credit will be available until May 20, 2025.Specialty Training for the New Era in Alzheimer's Disease: Building Skills for Making an Early Diagnosis and Implementing Disease-Modifying Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VQG865. CME/MOC/AAPA credit will be available until May 20, 2025.Specialty Training for the New Era in Alzheimer's Disease: Building Skills for Making an Early Diagnosis and Implementing Disease-Modifying Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/VQG865. CME/MOC/AAPA credit will be available until May 20, 2025.Specialty Training for the New Era in Alzheimer's Disease: Building Skills for Making an Early Diagnosis and Implementing Disease-Modifying Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.

  In this episode, we uncover a Connecticut World War II story that features airplanes without engines. Sound crazy? You'll learn how these engineless gliders helped beat the Nazis. Executive Producer Mary Donohue will also talk to the author of a new book that details the role that over 45 Connecticut companies played in producing the ammunition, weapons and machines that the United States needed as part of the massive war effort during World War II.   Her guests today are Connecticut author Sharon Cohen and Melissa Josefiak, Executive Director of the Essex Historical Society.   Cohen has authored several books. Her new book Connecticut Industries Unite for WWII Victory was published in 2023 and placed second in the 2024 New England Book Festival. Its available from High Point Publishing: www.highpointpub.com . Sharon Cohen is available for book talks and signings. Contact her at cohencomm1@earthlink.net   The Essex Historical Society has new publications on the three Essex villages-Ivoryton, Centerbrook and Essex, where much of today's story takes place. For information on the publications and programs of the Essex Historical Society, go to their website at https://www.essexhistory.org/ and follow them on Facebook and Instagram.   Subscribe to get your copy of Connecticut Explored magazine delivered to your mailbox or your inbox-subscribe at https://simplecirc.com/subscribe/connecticut-explored You won't want to miss our Summer issue with new places to go and lots of day trip ideas!   image: Courtesy of Essex Historical Society   ------------------------------------ You can help us continue to produce the podcast by donating directly to Grating the Nutmeg on the Connecticut Explored website here: https://ctexplored.networkforgood.com/projects/179036-support-ct-history-podcast-grating-the-nutmeg   Executive producer Mary Donohue is an award-winning author, historic preservationist and architectural historian. She can be reached at marydonohue@comcast.net   This episode of Grating the Nutmeg was produced by Mary Donohue and engineered by Patrick O'Sullivan at https://www.highwattagemedia.com/    Join us in two weeks for our next episode of Grating the Nutmeg, the podcast of Connecticut history.  

Learn about the differences between Alzheimer's and dementia, and how Alzheimer's disease progresses. We talk about why catching the disease early can make a big difference. Dr. Sharon Cohen and Dr. Yaakov Stern walk us through the stages of Alzheimer's disease, from when there are no symptoms to when memory issues start to show. They explain the stages of Alzheimer's and how it develops over time. We also hear from Kelly, who explains her personal experiences and concerns about developing Alzheimer's, and what she does about it.  For links to resources and information covered in this series, visit our website at HealthUnmuted.com/resources What did you think of this episode? We'd love to hear from you. Please visit healthunmuted.com/feedback to let us know! Rethinking Alzheimer's Disease was made possible with support from Eisai Inc. [00:03:10] What's the difference between Alzheimer's disease and dementia? [00:07:04] When does Alzheimer's begin to develop? [00:09:08] What is Mild Cognitive Impairment (MCI)? [00:10:36] What is subjective cognitive decline? [00:11:59] What is preclinical Alzheimer's disease? [00:13:13] Why is it important to detect Alzheimer's disease early? Disclaimer: The content provided in this podcast is intended for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard on this podcast. Reliance on any information provided by this podcast or its guests is solely at your own risk. ©2024 Mission Based Media Ltd • April 2024 • AD-M2059

Until recently, it was difficult for doctors to diagnose Alzheimer's disease with the limited tests available. Thankfully, there are now many different options to help doctors make an accurate diagnosis of Alzheimer's disease, even in its earliest stages.  In this episode of the "Rethinking Alzheimer's Disease" podcast, we learn about the tests that can help doctors tell whether someone is at risk of developing Alzheimer's disease.   Dr. Sharon Cohen, who knows about Alzheimer's both as a doctor and through her own family, shares how important it is to catch the signs early. She explains the steps of figuring out if someone has Alzheimer's, starting with noticing small changes in memory or mood, to more detailed checks by doctors, and even special scans that look at brain health. She also talks about the different reasons someone might start forgetting things or acting differently, and why it's crucial to get these symptoms checked out. It's not always Alzheimer's; sometimes, other health issues could be the cause.  Until just a few years ago, treatments could only help treat symptoms, not actually slow down the disease. Now, there's hope with advances that can change the course of the disease. Dr. Cohen stresses that knowing about Alzheimer's early gives people more choices, like planning ahead, deciding on treatments, or joining studies for new medicines.  The episode wraps up by encouraging people with Alzheimer's and their families to learn more and get support from organizations and doctors. This way, they don't have to face Alzheimer's alone and can find the best way to deal with it. For links to resources and information covered in this series, visit our website at HealthUnmuted.com/resources What did you think of this episode? We'd love to hear from you. Please visit healthunmuted.com/feedback to let us know! Rethinking Alzheimer's Disease was made possible with support from Eisai Inc. [01:49] Personal Insights from Dr. Sharon Cohen [02:31] What are the four steps to an Alzheimer's evaluation? [03:05] Step 1: Identifying early signs and symptoms [06:10] Step 2: Getting initial assessments - cognitive tests and medical history [08:19] Step 3: Referral to a neurologist and biomarker testing [11:01] Step 4: Diagnosis and management of Alzheimer's disease [12:33] Navigating diagnosis and treatment options Disclaimer: The content provided in this podcast is intended for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard on this podcast. Reliance on any information provided by this podcast or its guests is solely at your own risk. ©2024 Mission Based Media Ltd • April 2024 • AD-M2059

Alzheimer's disease is a complicated condition, but researchers are continuing to make important breakthroughs in our understanding of it. In this episode of the "Rethinking Alzheimer's Disease" podcast, we explore the new era of hope in Alzheimer's research and treatment.  Scientists and doctors are excited about the advancements in early detection and promising advances that could slow down or even prevent the disease. Dr. Sharon Cohen shares that for the first time, we can detect Alzheimer's in its earliest stages through simple blood tests, known as blood-based biomarkers. This breakthrough makes diagnosis more accessible and affordable, revolutionizing how we approach Alzheimer's care.  Additionally, artificial intelligence (AI) is being used to identify digital biomarkers, such as speech and movement patterns, further aiding in early detection. We also discuss the development of disease-slowing and prevention treatments, emphasizing the importance of clinical trials in bringing these innovations to the public. Moreover, the podcast highlights the critical need for equity and accessibility in healthcare to ensure that advancements in Alzheimer's research benefit all communities. Jason Resendez from the National Alliance for Caregiving discusses efforts to address disparities in healthcare and make new treatments more accessible.  As we conclude the Rethinking Alzheimer's Disease podcast, this episode brings messages of hope from various contributors. Thanks for your interest in Alzheimer's and the Rethinking Alzheimer's Disease podcast.   For links to resources and information covered in this series, visit our website at HealthUnmuted.com/resources What did you think of this episode? We'd love to hear from you. Please visit healthunmuted.com/feedback to let us know! Rethinking Alzheimer's Disease was made possible with support from Eisai Inc. [01:41] What's the future of Alzheimer's care? [02:41] Developments in blood-based biomarkers [05:11] AI and digital biomarkers [06:01] What are the advances in Alzheimer's treatments? [07:36] The importance of clinical trials in Alzheimer's research [09:23] Messages of hope Disclaimer: The content provided in this podcast is intended for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard on this podcast. Reliance on any information provided by this podcast or its guests is solely at your own risk. ©2024 Mission Based Media Ltd • April 2024 • AD-M2059

When Democrat Tom Suozzi won his special election last week, he thanked a lot of people. WNYC's Brigid Bergin reports Asian American voters were high on his list. Meanwhile, for the first time in the city's history, Staten Island will host an LGBTQ+ friendly St. Patrick's Day Parade, in addition to the original parade. Plus, tonight, the Juilliard School will present a special musical performance to honor Seneca Village, a 19th-century predominantly black community in Manhattan. Also, this weekend, a figure ice skating team from Howard University will make history as the first team from an HBCU to take part in an intercollegiate competition. WNYC's Michael Hill speaks with Sharon Cohen, founder of Figure Skating in Harlem to learn about the event.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we comprised some of the most interesting conversations from Mind Moments podcast episodes in 2023, highlighting research in neurology that moves the field forward. The NeurologyLive team included several reaction episodes to FDA approved medicines, providing clinicians an overview of what they can expect from these new therapies and how they will be used in clinic going forward. Those included in this week's episode, in order of appearance, are: Sharon Cohen, MD, FRCPC, behavioral neurologist and medical director of the Toronto Memory Program at the University of Toronto, and a trial investigator for Clarity AD, the phase 3 trial of lecanemab. Check out the full episode here: https://www.neurologylive.com/view/special-episode-lecanemab-approved-for-alzheimer-disease Robert A. Hauser, MD, MBA, director of the Parkinson's and Movement Disorders Center at the University of South Florida.Check out the full episode here: https://www.neurologylive.com/view/episode-81-widening-therapeutic-window-parkinson-disease Alberto Espay, MD, PhD, the division director and Research Endowed Chair of the James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, and a professor of clinical neurology and rehabilitation medicine at the University of Cincinnati.Check out the full episode here: https://www.neurologylive.com/view/episode-94-discussion-leqembi-lecanemab-approval-alzheimer-disease Carolina Ferreira Atuesta, MD, MSc, a scientific researcher and clinical data manager at the Icahn School of Medicine at Mount Sinai.Check out the full episode here: https://www.neurologylive.com/view/episode-82-managing-seizures-after-ischemic-stroke Natalie Goedeker, CPNP, a nurse practitioner in neurology in the Neuromuscular Division at Washington University in St Louis.Check out the full episode here: https://www.neurologylive.com/view/special-episode-tofersen-approved-sod1-als Want more Mind Moments episodes? Click here for all of NeurologyLive®'s podcast episodes. Episode Breakdown: 1:20 – Cohen on the safety of lecanemab, including the 3 patient deaths reported in the supportive clinical trial program.  6:25 – Hauser on the clinical advantages of IPX203, a potential new carbidopa/levodopa formulation for patients with Parkinson disease.  9:20 – Espay on tempering expectations of lecanemab and other antiamyloid therapies in the treatment of Alzheimer disease. 13:20 – Atuesta on the lack of standardized methods for monitoring patients with poststroke seizures, including elders. 17:00 – Goedeker on the approval of gene therapy SRP-9001 for patients with Duchenne muscular dystrophy, the integration process, and safety considerations clinicians should be aware of. This episode is brought to you by Medical World News, a streaming channel from MJH Life Sciences®. Check out new content and shows every day, only at medicalworldnews.com. Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Connecticut's industrial manufacturers were huge contributors to military success in World War Two. From half the aircraft engines used in the war (made by Pratt & Whitney in East Hartford) to submarines (Electric Boat, Groton), a large percentage of the billions of bullets used and guns for soldiers (Remington Arms, Bridgeport), and large and small items: “G-force” suits to allow pilots to maneuver their planes without losing consciousness, radar advancements, parachutes, rubber boots, ball bearings, air compressors for torpedoes, and periscopes. Hear the impressive story from Sharon Cohen, who has written a book that documents these fascinating contributions.

It's an exciting time for the fields of nutrition and neurology. This year, two large studies determined that taking a daily multivitamin could improve memory and cognition in older adults. So can supplements actually improve your brain health? How else can food choices affect cognitive function? Here, our Eat host, Leslie Beck, RD, is joined by Toronto Memory Program medical director Dr. Sharon Cohen to provide a comprehensive guide to multivitamins and cognition. Check out the episode webpage for links and more info.

Your daily highlights of Toronto Today with Greg Brady, Sheba Siddiqui & Gord Rennie. On today's episode: 1 - Greg says "I know how valuable weather forecasts are…but I'm guessing what you don't need is newspapers telling you NOT TO GO OUTSIDE". Agree? (0:15 - 10:05) 2 - Greg asks your opinion on climate change doomsayers. (10;11 - 19:26) 3 - Greg & Sheba talk about the Barbie movie. (19:32 - 30:20) 4 - Dr. Sharon Cohen, Medical Director at the Toronto Memory Program. (30:26 - 39:10)

Sharon Cohen, neurologist and medical director of the Toronto Memory Program Learn more about your ad choices. Visit megaphone.fm/adchoices

Your daily highlights of Toronto Today with Greg Brady, Sheba Siddiqui & Gord Rennie. On today's episode: 1 - Greg says "I know how valuable weather forecasts are…but I'm guessing what you don't need is newspapers telling you NOT TO GO OUTSIDE". Agree? (0:15 - 10:05) 2 - Greg asks your opinion on climate change doomsayers. (10;11 - 19:26) 3 - Greg & Sheba talk about the Barbie movie. (19:32 - 30:20) 4 - Dr. Sharon Cohen, Medical Director at the Toronto Memory Program. (30:26 - 39:10)

The FDA is granting full approval to a potential breakthrough Alzheimer's drug. Leqembi is the first drug proven to slow the memory-loss disease. Other approved drugs only target its symptoms. We spoke with one of the investigators behind the hefty clinical trial around this drug, Dr. Sharon Cohen, as well as one of her patients who has been trialing the drug. ((00:00)) Several Connecticut volunteers with the American Red Cross are heading to Vermont to help following the catastrophic flooding. We got the details on the upcoming deployment and also spoke about water safety this summer, with John Godin. ((06:40)) Pizza and Brewfest is coming to the Hartford Healthcare Ampitheater. It's the first of its kind festival in Connecticut. We spoke with BRBC President Dan Onofrio about the Amp and how it's become a model of maximizing space for an outdoor venue. We also touched on the kickoff of an annual farmers market and a big change for Bridgeport Islanders' hockey coach. ((19:00)) IMAGE CREDIT: iStock / Getty Images Plus

Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More

Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More

Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More

Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More

Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More

Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More

Welcome to this special episode of the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In 2022 and onward, whenever the FDA makes a major decision for the field of neurology, we'll be releasing short special episodes to offer a snapshot of the news, including the main takeaways for the clinical community, as well as highlights of the efficacy and safety profile of the agent in question. In this episode, we're covering the recent approval of lecanemab (Leqembi; Eisai) in Alzheimer disease. Offering commentary is Sharon Cohen, MD, FRCPC, a behavioral neurologist and medical director of the Toronto Memory Program at the University of Toronto, and a trial investigator for Clarity AD, the phase 3 trial of the antiamyloid agent. Lecanemab was approved via the accelerated approval pathway, with the application supported by data from the phase 2b proof-of-concept clinical trial, known as Study 201 (NCT01767311). The pivotal phase 3 Clarity AD trial (NCT03887455) is anticipated to serve as supplementary data and is pending review by the FDA. For more of NeurologyLive®'s coverage of lecanemab's approval, head here: FDA Approves Eisai's Lecanemab for the Treatment for Alzheimer Disease For more coverage of Alzheimer disease and dementia, head to NeurologyLive®'s Alzheimer & Dementia clinical focus page. Episode Breakdown: 0:30 – Lecanemab (Leqembi; Eisai) approved for Alzheimer disease 1:35 – Sharon Cohen, MD, FRCPC, on the approval 3:15 – Supporting context on the accelerated approval pathway for lecanemab 4:50 – Questions about access amid current CMS guidance 6:25 – Data from the supporting phase 2 study, Study 201 7:15 – Safety and the 3 patient deaths reported in the clinical trial program Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com. REFERENCES 1. FDA grants accelerated approval for Alzheimer's disease treatment. FDA. News release. January 6, 2023. Accessed January 9, 2023. https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment

Research into therapies for Alzheimer's disease and dementia is progressing, and one day soon we may reach a point where those at high risk for cognitive impairment may be able to delay onset for so long that they never experience symptoms. How does Alzheimer's really affect the brain, and how are doctors getting better at diagnosing it? Are there things we can do every day to reduce our risk? To learn about the latest in prevention, diagnosis and treatment, Medcan senior medical consultant Dr. Lorne Greenspan and clinical director of genetics Jessica Gu check in with a global expert on the disease, Dr. Sharon Cohen of Toronto Memory Program, to hear about the state of the art in Alzheimer's. Check out the episode webpage for links and more info.

In deze aflevering persvoorlichter van Museum en Depot Boijmans van Beuningen, Sharon Cohen. Zij vertelt over de hectiek rondom de opening van het Depot afgelopen november, de vele initiatieven die het museum ontplooit, haar aanstaande switch van persvoorlichter naar de marketingafdeling van het museum en nog veel, veel meer…. (Muziek Intro / Outro: ‘I Can't Find The Words To Say' door Onyx Ashanti)

Last June, the American Food and Drug Administration conditionally approved aducanumab, marketed as Adulehm, to treat those suffering from early Alzheimer's and other forms of dementia. It's the first drug in nearly 20 years to gain some kind of approval, even though other countries' health agencies, including Canada's, are still reviewing the data. There are concerns the drug causes brain bleeding and swelling, and may not be an effective treatment. Nonetheless, it's a massive step forward for a disease that affects at least 44 million people worldwide, including 750,000 Canadians, with real patients taking the drug in clinical trials right now. To mark January as Alzheimer's Awareness Month, we're joined by Sharon Cohen, a neurologist who runs Canada's busiest memory clinic, in Toronto. Cohen's usually got more than a dozen research projects and clinical trials with different drugs and treatments on the go. She's hoping one of them—maybe aducanumab—will turn out to be the cure. What we talked about: Learn about the Toronto Memory Program at torontomemoryprogram.com Register for Cohen's lecture on Jan. 26, 2022, here Read "Doctor provides hope to those who can't remember" at thecjn.ca Credits The CJN Daily is written and hosted by Ellin Bessner (@ebessner on Twitter). Victoria Redden is the producer. Michael Fraiman is the executive producer. Our theme music is by Dov Beck-Levine. Our title sponsor is Metropia. We're a member of The CJN Podcast Network; find more great Jewish podcasts at thecjn.ca.

Lori La Bey will be talking with Dr. Sharon Cohen a neurologist specializing in Alzheimer's disease diagnosis, care, and research. She is the medical director of Toronto Memory Program.  In addition, Valene Campbell will be joining us.  She is the Founder and Managing Director of ReVitahealth Inc., a home health care agency serving the Greater Toronto Area. Valene is also a children's book author and we learn about her book regarding dementia.   Contact Dr. Sharon Cohen with the Toronto Memory Program          Phone       416-386-9606          Email Valene Campbell        website www.valenecampbell.com           Email          Social Media @valenecampbell_   Contact Lori La Bey with questions or branding needs at www.AlzheimersSpeaks.com Alzheimer's Speaks Radio - Shifting dementia care from crisis to comfort around the world one episode at a time by raising all voices and delivering sounds news

Alex talk with Dr. Sharon Cohen, the Head Medical Director at Toronto Memory Program about a new medication that could help actually treat Alzheimer's. And its the first one since 2003. Let's get talking See omnystudio.com/listener for privacy information.

Sharon was devastated when she learned of her mother's diagnosis of ovarian cancer. She felt like there was not much offered to her mother in the way of nutritional or emotional support. After months of healing on her part through wonderful counseling and self-empowerment courses, she set out on a mission to find the pieces of the puzzle that was missing from the existing healthcare system. She soon realized that disease is alleviated by restoring a healthy balance to mind, body, and soul through proper nutrition, physical activity, stress management techniques, and some gentle guidance towards self-awareness and self-responsibility. Her curiosity and desire for living a healthy, holistic lifestyle turned a passion into a profession. She uses her vast knowledge, training, and more than 20 years of experience as a certified naturopath, Bioset intolerance practitioner, and craniosacral therapist to help women to recognize that radiant health lies within their innate wisdom. In this episode of the Fall In Love with Fitness podcast, Sharon and I discuss the touching story of how she became a Holistic Naturopath, why most people struggle to achieve their goals, and why having a healthy mind is extremely important if you want to have a healthy body.

In our last episode, we told you why organizational purpose is important. In this episode, we're going to show you by talking to a leader in one of the industries hit the hardest by the COVID-19 pandemic. Sharon Cohen, Vice President Fairmont Hotels & Resorts, joins us to tell us how a clear, shared purpose among leaders and their teams is helping her people strengthen their sense of community and thrive in this challenging time.

Sharon Cohen is the Vice President, Fairmont Brand at Accor, one of the largest hospitality companies in the world. Originally founded in 1967 and headquartered in the Greater Paris Region, Accor has grown into a holistic ecosystem of more than 30 brands, 80 partnerships, and more than 5,000 hotels in 110 countries. Originally from Canada, Sharon has more than 20 years of experience in hospitality brand management, loyalty programs, and customer relations. She began her career as a Manager at Fairmont's national sales office in New York, back in 2000, and she's been with Fairmont ever since – with the exception of a brief hiatus while the brand was being acquired by Accor in 2016. She rejoined the company in 2017 to take on her current role, and she is now based in Paris. As the leader of the Fairmont brand within Accor, Sharon is responsible for Fairmont's global brand strategy, product development, positioning and brand standards. She works closely with other teams in AccorHotels' Luxury Brands organization to enhance and differentiate Fairmont's competitive position in the luxury hotel segment. In this interview, Sharon talks about how Fairmont Hotels & Resorts evolved to become the iconic global brand we know today. “Unforgettable since 1907”, Fairmont has stayed true to its core positioning across decades, cultures, geographies, and mergers. Find out how this venerable hospitality brand has been able to adapt to changing consumer trends, keep its branding relevant, and respond proactively to current global challenges.   Links: Fairmont Hotels & Resorts website Fairmont on LinkedIn Fairmont on Facebook Fairmont on Instagram Fairmont on YouTube Fairmont on Twitter Accor website Accor on LinkedIn Accor on Twitter Sharon on LinkedIn   This episode was sponsored by Vistatec.

Composer David Friedman stops by to reminisce about his favorite Regis Philbin memories. Then joining Lisa are Sharon Cohen and Robert Schmidt on Trauma and COVID-19 - you can check them out at www.disastermentalhealthplan.com!

Too many Late Bloomers? Peter Pans? Stunted Adolescents? Or does patience make perfect? Dr. Sharon Cohen joins The Debate Team to talk emotional availability, mid-life maturity, dating with intention, owning your status, living without regret, sending strong signals, the purpose of judgment, and why there's no better time than the right time!

Too many Late Bloomers? Peter Pans? Stunted Adolescents? Or does patience make perfect? Dr. Sharon Cohen joins The Debate Team to talk emotional availability, mid-life maturity, dating with intention, owning your status, living without regret, sending strong signals, the purpose of judgment, and why there's no better time than the right time!

Neil Armstrong and Buzz Aldrin made history 50 years ago, July 20, 1969, during a decade that was as much about the space race as it was music and changing social norms. Former Canadian astronaut Bob Thirsk shares his recollections about the Apollo 11 landing and predicts where men and women will go next, and when! AND About 50-million people worldwide are living with dementia and Alzheimer's is the most common form, a big conference in L-A has just concluded. Experts and scientists shared the latest findings on research in the field. The medical director of the Toronto Memory Program Dr. Sharon Cohen, joined us to share these findings with you.

All about Feminine Energy My guest Sharon Cohen, PhD has been working in the mental health field for over 25 years. She has also specialized in love and relationships for the past 7 years, but as she states during the interview, she has always been passionate about the subject. Her main clientele is women in their 30's and 40's, but she does work with men as well! She says she is committed to helping women find the right relationship for them. In this episode, in particular, she taps into her knowledge base to teach us about the dynamic energy fields at the root of all relationships. Often there are masculine and feminine interplays in energy and the best, most stable relationships have a healthy balance of the two. She talks much more in-depth about this fascinating subject within. Enjoy! The Red, Yellow, and Green Flags of a Relationship In Sharon's program, she has something called the red/yellow/green flag process, in which she helps her clients to become aware of the people to avoid, as well as the people to pursue a lasting, healthy relationship for you. Sharon says believes that it's really important to know completely what you don't want in a relationship. So she has her clients make a list of the 3 non-negotiables to make sure that once the honeymoon period ends in a relationship, the negative qualities they don't want will not surface unexpectedly. The Importance of Self-Awareness Sharon says that some clients work under the assumption and belief that all of the people they've dated are the problem instead of taking some of the ownership for relationship troubles. She said that self-awareness is key to having a healthy relationship, and it's challenging to work with clients who don't have any self-awareness. This goes hand in hand with being willing to change. As Sharon shares, if you're not willing to change, then no change will happen. Common Mistakes Her Clients Are Making A common problem that some of her clients run into is that many of the women feel they have to stop being confident and independent in their work life to have a relationship. But she says that for those who say they want to be completely independent, they might as well not be in a relationship. Relationships, by definition, require interdependency In addition, she also comes across difficulties regarding the dynamic between feminine and masculine energies. For those who are not aware, a balance of masculine and feminine energies seems to spark a healthier interplay during a relationship. These energies are not the same as your gender identity. All people can have both masculine and feminine energy, and each couple functions better if both energies are represented. Couples often struggle when feminine energy is lacking. Understanding all of this is very important and Sharon talks much more about it within the episode! Energy Dynamic Within Same-Sex Couples Sharon says that even with same-sex couples, some people will tend to be more masculine than feminine in their energies. Again, gender identity is not the defining characteristic here. There is an energy range that fluctuates and changes regularly. Working with Sex Sharon says that she works with couples who have trouble communicating their individual sexual desires. Giving each partner a voice and opportunity to respond in an open way is vital for any healthy, fulfilling relationship. She uses a script that is kind of awkward at first, but also somewhat humorous. And through that practice and approach, the difficult subject can be broached in an effective, non-intimidating way. Key Links for Dr. Sharon Cohen Sharon's website (check out her free-ebook and make a consultation with Sharon!): https://drsharoncohen.com/ More info: Book and New Course – https://sexwithoutstress.com Web – https://www.bettersexpodcast.com/ Sex Health Quiz – http://sexhealthquiz.com/ If you're enjoying the podcast and want to be a part of making sure it continues in the future, consider being a patron. With a small monthly pledge, you can support the costs of putting this show together. For as little as $2 per month, you can get advance access to each episode. For just a bit more, you will receive an advance copy of a chapter of my new book. And for $10 per month, you get all that plus an invitation to an online Q&A chat with me once a quarter. Learn more at https://www.patreon.com/bettersexpodcast Better Sex with Jessa Zimmerman https://businessinnovatorsradio.com/better-sex/More info and resources: How Big a Problem is Your Sex Life? Quiz – https://www.sexlifequiz.com The Course – https://www.intimacywithease.com The Book – https://www.sexwithoutstress.com Podcast Website – https://www.intimacywithease.com Access the Free webinar: How to make sex easy and fun for both of you: https://intimacywithease.com/masterclass Secret Podcast for the Higher Desire Partner: https://www.intimacywithease.com/hdppodcast Secret Podcast for the Lower Desire Partner: https://www.intimacywithease.com/ldppodcast

Episode Summary On this episode, I chat with Sharon Cohen, Naturopath. Sharon is passionate about bringing medicine and natural healing together. Naturopathy is based on the natural healing properties in nature. Sharon believes every cell has the ability to heal itself if given the right environment. Today we are getting off the fence and getting healthy! We talk about reconnecting with yourself, intuitive eating, bringing awareness into your life and how to foster a healthier life and a healthier you. Meditation is one of many strategies discussed to help center yourself and release stress from your life. All meditation really is, is being in the here and now. Sharon shares many great insights as well as wisdom during this episode. In This Episode What a Naturopath is How Sharon got into this line of work Things you can do right now to lift your mood Reconnecting with yourself Common issues Sharon sees in her practice Intuitive eating and listening to your body Honoring and welcoming food into our body Being aware and awake in how you feel Toxins in the body How hair analysis can show the metals you carry in your body Releasing metals from your body Utilizing natural deodorant Hormone saliva testing Staying centered during the day or while sleeping Developing a meditation practice Emotional Freedom Technique Sharon Cohen Bio Sharon Cohen is living her best life by helping women to do the same when it comes to their health and well-being. She uses her perceptive interpersonal skills and extensive knowledge of naturopathic medicine to help women to make the connection between any troubling symptoms and what they may be having difficulty integrating into their lives. Some life disruptions might include a divorce or separation, children growing up and leaving home, the death of a relative or a major change at work. In a safe and nurturing environment, Sharon helps women to discover how to turn ‘dis-ease' into an opportunity for health and wholeness. Her strong listening skills, caring attitude and natural empathy lie at the heart of her practice. Visit Sharon Cohen at SharonCohen.ca Links Native Deodorant Emotional Freedom Technique Learn More about Your Host Teaching Empowered Living, Erica Diamond is a leading Expert in Lifestyle, Wellness and Empowerment. A Certified Life Coach and Certified Yoga Instructor, Erica is the Founder and Editor-In-Chief of the Award-Winning Lifestyle Platform EricaDiamond.com® (previously WomenOnTheFence.com®), Lifestyle and Parenting Correspondent on Global TV, Award-Winning Entrepreneur, Keynote Speaker, Spokesperson, and Author of the women's entrepreneurial book, 99 Things Women Wish They Knew Before Starting Their Own Business. Erica founded the Global Get Off The Fence Movement inspiring people worldwide to get off the fence, get unstuck and thrive, and launched The Erica Diamond Podcast in summer 2019 to spotlight trailblazers and change makers around the world.  Erica Diamond has been named to the coveted list of The Top 20 Women in Canada as well as FORBES Magazine's Top 100 Sites for Women and FORBES 25 Most Influential Women In Entrepreneurship on Twitter. Erica Diamond was the Spokesperson for National Entrepreneurship Day and is a Huffington Post contributor.  To learn more about Erica Diamond, visit her at EricaDiamond.com! Don't forget to SIGN UP for Erica's newsletter and tips: http://eepurl.com/hdfq65 If you liked this, then listen to the podcast episode for even more. And don't forget to subscribe to the show!

As we celebrate Valentine's Day this week (and yes, we realize this is a totally made up “holiday”), we thought it'd be fun to talk about love and relationships as a lawyer. Lawyers are busy and often work long hours so finding time to date or nurture a loving relationship can often be difficult. Joining me today is Dr. Sharon Cohen, relationship and love consultant.  She received her PhD from the University of Texas and has been helping busy professionals have committed and fulfilling relationships. Dr. Cohen shares why it's important for women to tap into their inner energy when seeking a partner, how you can reignite the spark in a long-term relationship, and how to make time for your loved ones.   Contact Information: sharon@drsharoncohen.com www.drsharoncohen.com A huge thank you goes to our two show sponsors: LexisNexis: From predictive analytics to research solutions, legal tools from LexisNexis can help you research more thoroughly, work more efficiently and build stronger strategies. Visit http://lexisnexis.com/podcast for Terms and Conditions and to see how you can get a custom solution tailored precisely for your budget. Abby Connect:Abby Connect, the live receptionist service loved by small businesses.  Get your 2-week free trial and $95 off your first month at http://abbyconnect.com/genwhy Thanks for Checking Out the Show Notes and for Listening! I really hope you enjoyed this episode. I would really appreciate it if you shared this episode with a friend who could benefit from listening to this particular episode.  A special thanks to our sponsors Abby Connect and LexisNexis. If you haven't already, please don't forget to subscribe to the GWL Podcast in Apple Podcasts or in Stitcher Radio. That way, every time I prepare a new episode for you, it'll automatically show up in your phone.  

Bob Komsic fills in for Libby Znaimer. 25 thousand new cases of Alzheimer

Bob Komsic fills in for Libby Znaimer. 25 thousand new cases of Alzheimer's disease are diagnosed every year in Canada. Doctors and researchers on the front lines are doing everything to reverse this alarming stat including a new cheek swab test now being used here in Toronto. Bob speaks to Dr. Sharon Cohen, Medical Director of the Toronto Memory Program, about potential breakthroughs in treatments. And – When Gord Downie died last October, the nation mourned. Some have called ‘The Tragically Hip' the most Canadian rock band ever. Bob talks with author Michael Barclay about his new biography, “The Never-Ending Present” on Gord Downie and his band of brothers.

Welcome to episode 55 of the Sexology Podcast, today I am delighted to be joined again by Dr. Sharon Cohen who talks to us about why sexual chemistry is a necessity for any relationship to thrive, learning to enjoy the stability of relationships and the technological impacts that apps like Tinder have had on modern relationships. Dr. Sharon Cohen is a Relationship and Love Consultant in Newport Beach, California. She works with women who can't seem to find the right relationship or who aren't sure they are in the right relationship. Sometimes clients who come to her are ready to give up on love. She helps them have supportive, committed, deeply loving relationships with a man who ROCKS THEIR WORLD. Her vision of success is that all women who want to be will be in relationships of ever-lasting love with their “meant-to-be” partners, feeling connected and loved. Her primary mission is to help women gain the skills to attract and keep long-lasting love. A sub-set of that mission is to get women inspired to attract the love they desire. Her expertise and life experiences support in sparking awareness and prompting change in her clients. Using an educational and action-oriented program, Dr. Sharon's clients see their interactions and relationships in a whole new light. With this new-found awareness, her clients free themselves from their past mistakes in their dating, relationships, and life so they can now relax into love. She has a background in psychotherapy and now works as a consultant, ready to offer you expert advice as to what it is you are doing wrong. Her experience is that the clients who are coming to see her don't know what it is they are doing that isn't working and they are ready to get that guidance. She currently sees clients in her office, on “walk & talks” outside of the office and via phone calls for people who aren't in the local area.   In this episode, you will hear:   The underlying reasons we go back to unhealthy relationships Why sexual chemistry is a necessity for any relationship to thrive Learning to enjoy the stability of relationships The amount of time you should give to a person before deciding it's not working Technological impacts that apps like Tinder have had on modern relationships Giving time to become attracted to a person's personality The warning signs to look for when going on dates with strangers   Complimentary Breakthrough to Deep Love phone consultation - write Dr. Sharon at sharon@drsharoncohen.com and say you heard about this offer through Sexology podcast.  Resources http://drsharoncohen.com sharon@drsharoncohen.com www.facebook.com/drsharoncohen   To book an appointment with Dr. Moali (50% Discount until Valentine's day) please visit – https://oasis2care.clientsecure.me/client_portal      

Welcome to episode 53 of the Sexology Podcast, today I am delighted to be joined by Dr. Sharon Cohen who talks to us about how to decide if you are emotionally ready to have sex with your date, putting communication at the heart of your relationship and the importance of negotiation when it comes to consensual sexual activity.   Dr. Sharon Cohen is a Relationship and Love Consultant in Newport Beach, California. She works with women who can't seem to find the right relationship or who aren't sure they are in the right relationship. Sometimes clients who come to her are ready to give up on love. She helps them have supportive, committed, deeply loving relationships with a man who ROCKS THEIR WORLD.   Her vision of success is that all women who want to be will be in relationships of ever-lasting love with their “meant-to-be” partners, feeling connected and loved. Her primary mission is to help women gain the skills to attract and keep long-lasting love.   A sub-set of that mission is to get women inspired to attract the love they desire. Her expertise and life experiences support in sparking awareness and prompting change in her clients. Using an educational and action-oriented program, Dr. Sharon's clients see their interactions and relationships in a whole new light. With this new-found awareness, her clients free themselves from their past mistakes in their dating, relationships, and life so they can now relax into love.   She has a background in psychotherapy and now works as a consultant, ready to offer you expert advice as to what it is you are doing wrong. Her experience is that the clients who are coming to see her don't know what it is they are doing that isn't working and they are ready to get that guidance.   She currently sees clients in her office, on “walk & talks” outside of the office and via phone calls for people who aren't in the local area.       In this episode, you will hear:   How to decide if you are emotionally ready to have sex with your date? How can you assess the partner is ready? Reestablishing sexual boundaries after they've gone too far Putting communication at the heart of your relationship Learning to communicate more face to face and less via texting How long we should continue going out with someone when there is no sexual chemistry? The importance of negotiation when it comes to consensual sexual activity   If you are a listener of the Sexology podcast, one of the best ways to support our show is to leave us an honest review on iTunes. Those that give us an honest review on iTunes during January 2018 will be eligible for a Free T shirt during the month on January. All you need to do is to take a screenshots of your review and post it at one of the following social media platforms:   https://www.facebook.com/oasis2care https://twitter.com/oasis2care   You can also email the screen shot to us at drmoali@sexologypodcast.com    Resources http://drsharoncohen.com

An international Alzheimer's Conference was in Toronto discussing new treatments and innovation, but Dr. Sharon Cohen joined Libby to talk about why current methods and medications aren't being followed.Plus, the Ontario government is pulling the plug on funding for high doses of Opioid medications like Fentanyl to help curb addiction. Libby speaks with Dr. Darren Cargill about why that's bad news for palliative care.

An international Alzheimer's Conference was in Toronto discussing new treatments and innovation, but Dr. Sharon Cohen joined Libby to talk about why current methods and medications aren't being followed.Plus, the Ontario government is pulling the plug on funding for high doses of Opioid medications like Fentanyl to help curb addiction. Libby speaks with Dr. Darren Cargill about why that's bad news for palliative care.